ACell
Columbia
About ACell
ACell, Inc. engages in the development and commercialization of extracellular matrix devices to repair and remodel damaged tissues and organs in a range of surgical procedures for the U.S. and international patents. It offers MatriStem technology, a non-crosslinked, resorbable, and acellular material; MatriStem Wound Care Matrix, a wound care device with regenerative medicine technology; MatriStem Plastic Surgery Matrix, a plastic surgery and wound care device; and MatriStem Hernia Matrix, a general surgery device. The company was incorporated in 1999 and is headquartered in Columbia, Maryland. It has a manufacturing facility in Lafayette, Indiana.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $50K – $100K
- Total funding: $8.7M
- Funding stage: M&A
- Last round: Series Unknown (Apr 2011)
- Website: acell.com
- Phone: 4107154511
Industries & Categories
Health Care, Manufacturing, Medical
Social Profiles
Canonical: https://fsome.com/organization/acell-2430260 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.